Latvian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Lappuse 1 no 27 rezultātiem
Low density lipoprotein nanocarriers for targeted delivery of omega-3 polyunsaturated fatty acids to cancer
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the field of cancer treatment. More particularly, it concerns methods of generating DHA-containing lipid nanoparticles and their use in the treatment of cancer.
2. Description of Related Art
In recent
Uses of hydroquinone substituted polyunsaturated fatty acids as antioxidants
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not applicable
REFERENCE TO A "MICROFICHE APPENDIX"
Not applicable
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to hydroquinone substituted polyunsaturated fatty acids. More particularly, the
Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
TECHNICAL FIELD
The invention relates to therapeutic agents and methods for treating cancer, and especially for overcoming multidrug resistance, including multidrug resistance in cancer stem cells. In particular, the invention relates to nanoemulsion formulations and delivery systems for taxoid
Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
FIELD OF THE DISCLOSURE
The present document relates to the field of medicinal chemistry. More particularly it relates to the field of active agents used as cancer chemopreventive agent and radioenhencer for radiotherapy of cancer.
BACKGROUND OF THE DISCLOSURE
An estimated 153,100 new cases of
Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
FIELD OF THE DISCLOSURE
The present document relates to the field of medicinal chemistry. More particularly it relates to the field of active agents used as cancer chemopreventive agent and radioenhencer for radiotherapy of cancer.
BACKGROUND OF THE DISCLOSURE
An estimated 153,100 new cases of
Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
FIELD OF THE DISCLOSURE
The present document relates to the field of medicinal chemistry. More particularly it relates to the field of active agents used as cancer chemopreventive agent and radioenhencer for radiotherapy of cancer.
BACKGROUND OF THE DISCLOSURE
An estimated 153,100 new cases of
Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
FIELD OF THE DISCLOSURE
The present document relates to the field of medicinal chemistry. More particularly it relates to the field of active agents used as cancer chemopreventive agent and radioenhencer for radiotherapy of cancer.
BACKGROUND OF THE DISCLOSURE
An estimated 153,100 new cases of
Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
FIELD OF THE DISCLOSURE
The present disclosure relates to the field of medicinal chemistry. More particularly, it relates to polyunsaturated fatty acid monoglyceride compounds and derivatives thereof. It also relates to compositions which comprise such compounds. There is also provided a method for
Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
FIELD OF THE DISCLOSURE
The present disclosure relates to the field of medicinal chemistry. More particularly, it relates to polyunsaturated fatty acid monoglyceride compounds and derivatives thereof. It also relates to compositions which comprise such compounds. There is also provided a method for
Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
FIELD OF THE DISCLOSURE
The present disclosure relates to the field of medicinal chemistry. More particularly, it relates to polyunsaturated fatty acid monoglyceride compounds and derivatives thereof. It also relates to compositions which comprise such compounds. There is also provided a method for
Method for treating an inflammatory disease with compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
FIELD OF THE DISCLOSURE
The present disclosure relates to the field of medicinal chemistry. More particularly, it relates to polyunsaturated fatty acid monoglyceride compounds and derivatives thereof. It also relates to compositions which comprise such compounds. There is also provided a method for
Methods for selectively occluding blood supplies to neoplasias
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to methods for selectively occluding blood vessels which supply neoplastic tissue, including tumors.
2. Description of the Related Art
The polyunsaturated fatty acids (PUFAs) are fatty acids having at least two
Method of treating human breast cancer by administration of radiolabeled antibody and unsaturated fatty acids
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
TECHNICAL FIELD
This invention relates to a method for enhancing existing cancer therapies by additionally administering unsaturated fatty acids to a patient. More particularly, this invention relates to a method for enhancing existing breast cancer therapies such as surgery, chemo-, hormone- and
Nucleobase analogue derivatives and their applications
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
BACKGROUND
Pancreatic cancer is the fourth most common cause of cancer-related deaths in the United States and the eight worldwide. The Pancreatic Cancer Action Network.TM. predicted that it will move from the 4.sup.th to the 2.sup.nd leading cause of cancer death in the US by 2020 or earlier, based
Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a method of reducing damage to skin and mucosa in pet animals such as dogs and cats wherein the pet is afflicted with cancer and is subjected to radiation therapy, the method including a food composition to be
Vispilnīgākā ārstniecības augu datu bāze, kuru atbalsta zinātne
- Darbojas 55 valodās
- Zāļu ārstniecības līdzekļi, kurus atbalsta zinātne
- Garšaugu atpazīšana pēc attēla
- Interaktīva GPS karte - atzīmējiet garšaugus atrašanās vietā (drīzumā)
- Lasiet zinātniskās publikācijas, kas saistītas ar jūsu meklēšanu
- Meklēt ārstniecības augus pēc to iedarbības
- Organizējiet savas intereses un sekojiet līdzi jaunumiem, klīniskajiem izmēģinājumiem un patentiem
Ierakstiet simptomu vai slimību un izlasiet par garšaugiem, kas varētu palīdzēt, ierakstiet zāli un redziet slimības un simptomus, pret kuriem tā tiek lietota.
* Visa informācija ir balstīta uz publicētiem zinātniskiem pētījumiem
